Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice

In acquired hemophilia A (AHA), autoantibodies to coagulation factor VIII (FVIII) neutralize FVIII activity leading to a potentially severe bleeding diathesis that carries a high rate of morbidity and mortality. This disorder is rare and occurs mainly in adults over 60 years of age or in the postpar...

Descripción completa

Detalles Bibliográficos
Autores principales: Pishko, Allyson M, Doshi, Bhavya S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112043/
https://www.ncbi.nlm.nih.gov/pubmed/35592586
http://dx.doi.org/10.2147/JBM.S284804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112043/
https://www.ncbi.nlm.nih.gov/pubmed/35592586
http://dx.doi.org/10.2147/JBM.S284804

Ejemplares similares